Thomas Jefferson University

IDO2 an active enzyme to target in pancreatic cancer

An enzyme that is overexpressed in pancreatic cancer cells may hold the key to successfully treating the disease with targeted immunotherapy, researchers from Thomas Jefferson University reported at the 2008 Annual Meeting ...

dateDec 01, 2008 in Cancer
shares0 comments 0